GlassScriptPhysician profile
Carolyn Diaz
NPI 1366495368
$472.93
in general payments reported to CMS, 2019-2025
11 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.30 · 2023: $13.87 · 2024: $247 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $150.64 | 2025 | Aristada, Lybalvi, Aristada Initio |
| Baxter Healthcare | $83.96 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Neurelis, INC. | $34.23 | 2024 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $33.08 | 2025 | Uzedy |
| Astrazeneca Pharmaceuticals LP | $33.04 | 2024 | Airsupra, Breztri |
| Pfizer INC. | $32.37 | 2024 | |
| Exact Sciences Corporation | $28.35 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $28.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.90 | 2024 | Jardiance |
| Neurocrine Biosciences, INC. | $17.55 | 2024 | Ingrezza |
| Lilly USA, LLC | $13.51 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.